Results 181 to 190 of about 99,136 (277)

VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities

International Journal of Dermatology, Volume 65, Issue 3, Page 584-586, March 2026.
Kritin K. Verma, Kevin T. Nguyen, Daniel P. Friedmann, Helen Chen, Michelle B. Tarbox   +4 more
wiley   +1 more source

High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
SpliCOOL‐seq achieves high‐throughput single‐cell co‐profiling of DNA methylation and chromatin accessibility. DNMT inhibitors caused cancer cell demethylation with divergent patterns. SpliCOOL‐seq enables the discovery of genes related to LUAD tumorigenesis. Ageing and LUAD tumorigenesis may share similar epigenetic alterations.
Qingmei Shen, Enze Deng, Ling Luo, Jingna Zhang, Qifeng Yang, Dan Su, Xiaoying Fan   +6 more
wiley   +1 more source

Characteristics of Myelodysplastic Syndrome with Coagulation Abnormalities and Tailored Diagnosis and Treatment. [PDF]

J Pers Med
Imataki O, Uemura M, Kitanaka A.
europepmc   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source

A Forgotten Foe Returns: The Diagnostic Odyssey of Kala-Azar Masquerading as Myelodysplastic Syndrome in a Post-Elimination Era. [PDF]

Clin Case Rep
Mifty SK, Chowdhury SI, Rahman T, Khan TAR, Roy S, Ahmmed F, Hossain MS, Khalil I.   +7 more
europepmc   +1 more source

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen [PDF]

, 2017
Abboud, Camille N, Ali, Alaa M, Cashen, Amanda F, DiPersio, John F, Fehniger, Todd A, Gao, Feng, Ghobadi, Armin, Jacoby, Meagan A, Oh, Stephen T, Pusic, Iskra, Romee, Rizwan, Schroeder, Mark A, Stockerl-Goldstein, Keith E, Uy, Geoffrey L, Vij, Ravi, Wartman, Lukas D, Weisel, Daniel, Welch, John S, Westervelt, Peter   +18 more
core   +2 more sources

DNTTIP1 drives leukaemogenesis through MiDAC‐mediated epigenetic silencing of BMF

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
DNTTIP1 cooperates with SP1 to recruit HDAC1/2, leading to BMF silencing and reduced competitive binding of BMF to BCL2.This suppresses autophagy and apoptosis, promoting leukaemic cell survival. Targeting the DNTTIP1‐HDAC1/2‐BMF axis reactivates BMF and induces anti‐leukaemic effects.
Ruolin Xiu, Yuzhu Ma, Yueying Gao, Yao Chen, Xinyu Li, Yue Wu, Meiling Sun, Qizhao Li, Yanhong Zhao, Shuqian Xu, Shengjin Fan, Yongsheng Li, Huitao Fan   +12 more
wiley   +1 more source

Diagnostic pitfalls of ESA-resistant anemia due to functional copper deficiency in a dialysis patient: a myelodysplastic syndrome mimic. [PDF]

CEN Case Rep
Ikegishi Y, Abe R, Maehata A, Takiyama Y.   +3 more
europepmc   +1 more source

Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques

Head &Neck, Volume 48, Issue 2, Page E20-E24, February 2026.
ABSTRACT Background Partial laryngectomy has been well described as a management option for T1–3 laryngeal squamous cell cancers. However, there are a few case reports of partial laryngeal surgery for locally advanced thyroid carcinoma. Methods This is a case series of five patients with thyroid carcinoma (one primary and four recurrent) with laryngeal
Ella E. Hawes, Victoria E. Banuchi, Anastasios Maniakas, Jennifer R. Wang, Paul H. Graham, Julia D. Diersing, Naifa L. Busaidy, Maria E. Cabanillas, Ramona Dadu, Sarah Hamidi, Priyanka Iyer, Steven G. Waguespack, Salmaan Ahmed, Sahar Alizada, Alexandra Belcastro, Ranim Alsharif, Mimi I. Hu, Mark E. Zafereo   +17 more
wiley   +1 more source

Histone-based liquid biopsy discriminates between myelodysplastic syndrome and solid malignancies. [PDF]

Clin Epigenetics
Tsoneva DK, Buzova D, Bianco SD, Micheva I, Efraim M, Daskalova N, Resnick I, Teneva M, Chervenkov T, Conev NV, Manev R, Stoyanov DS, Cerveny J, Mazza T, Vinciguerra M.   +14 more
europepmc   +1 more source